| 000 | 01216 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250511202159.0 | ||
| 264 | 0 | _c19930609 | |
| 008 | 199306s 0 0 eng d | ||
| 022 | _a0960-314X | ||
| 024 | 7 |
_a10.1097/00008571-199111000-00006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLevitt, R C | |
| 245 | 0 | 0 |
_aUnderstanding biological variability in susceptibility to respiratory disease. _h[electronic resource] |
| 260 |
_bPharmacogenetics _cNov 1991 |
||
| 300 |
_a94-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAsthma _xetiology |
| 650 | 0 | 4 |
_aAtropine _xpharmacology |
| 650 | 0 | 4 |
_aBronchoconstrictor Agents _xpharmacology |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred Strains |
| 650 | 0 | 4 |
_aRespiratory Hypersensitivity _xetiology |
| 650 | 0 | 4 |
_aRespiratory System _xdrug effects |
| 650 | 0 | 4 |
_aSubstance P _xanalogs & derivatives |
| 773 | 0 |
_tPharmacogenetics _gvol. 1 _gno. 2 _gp. 94-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00008571-199111000-00006 _zAvailable from publisher's website |
| 999 |
_c1733347 _d1733347 |
||